The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gut–renal axis and incretin-based therapies might reduce the burden of diabetic kidney disease. Here, the authors ...

Pathophysiology behind symptoms and complications of diabetes. Polydipsia or increased thirst is due to high blood glucose that raises the osmolarity of blood and makes it more concentrated.

The Bottom Line. While circulating levels of GLP-1 are decreased in type 2 diabetes, tissue response to the hormone remains intact. Evidence suggests that an impaired incretin effect is a result ...

A new experimental treatment may be able to cure type 1 diabetes. About 83% of the patients were able to stop using insulin ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Mandal, Ananya. (2023, July 03). Diabetes Mellitus Type 2 Pathophysiology.

Pathophysiology of diabetes mellitus is a complex syndrome that causes abnormal metabolism of carbohydrate. It results in deficiency of insulin in the body. Written by: Deepika Majumdar; ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Pearson, ER, Velho, G, Clark, P, et al. β-Cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations ...

Since the discovery of insulin in 1921, it has saved millions of lives globally. From its first use in January 1922, it has transformed diabetes from a death sentence to a treatable chronic condition.